ArticleJournal of orthopaedic surgery and research2021

A 24-month retrospective update: follow-up hospitalization charges and readmissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2).

Bradley Wetzell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.